CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-08). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.7.
Verdict No. 2466 · Search date 2026-08-08 · Methodology v0.7

Eyelid cleansing wipes,
does it really help with Reduction of blepharitis-associated ocular symptoms?

30-Second Summary
C
Evidence Grade C · 50 · Safety acceptable
Pre-moistened wipes reduced four-week symptoms versus saline pads but were not superior to another active cleanser
No serious ocular adverse event or intolerance-related discontinuation was identified over four weeks. Stop use if irritation or allergy occurs.
What the
research shows
The grade is C. In a 72-participant single-center trial, baseline-adjusted Week 4 symptom VAS means were 27.47 with wipes and 40.83 with an identical pad moistened with 0.9% saline, a difference of -13.35 points (95% CI -21.51 to -5.20). The wipe was not superior to a pad moistened with 0.01% hypochlorous acid: -5.68 (-13.13 to 1.76).
What the
ads claim
It is not established that eyelid cleansers sold in Korea are compositionally identical to Aishiyoujia/EYESU+. A generic product name is insufficient to transfer the result.
*

Useful facts when choosing a product

  • The study wipe contained purified water, aloe leaf juice, purslane extract, glycerine, propylene glycol, panthenol, polysorbate 20, sodium lauroyl sarcosinate, butylene glycol, and p-hydroxyacetophenone.
  • Verdict 2412 is D with 28 points and concerns weekly 50% in-office plus daily 10% home tea-tree-oil cleansing for Demodex blepharitis. This is a different intervention from a different evidence source.
  • Warm compresses and other active blepharitis therapies were prohibited.
Gap Measurement · Verdict 2466 · C 50
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Shi et al. randomized 72 adults 1:1:1 to a pre-moistened wipe, a matched pad sprayed four times with 0.01% hypochlorous acid, or a matched pad sprayed four times with sterile 0.9% saline. All groups wiped the closed lid margin for 30 seconds twice daily for 28 days. The operational full analysis set was 21/22/21, while observed Week 4 VAS counts were 21/20/18. Unadjusted Week 4 means were 29.36±13.79, 34.20±3.59, and 37.47±18.21. Registration ChiCTR2500101040 was cited, but its public record could not be opened to verify endpoints, comparators, and analysis. The manuscript PDF states, “The authors received no specific funding for this work,” while the publisher page lists three Chinese public grants. Product provision was not reported.

02

Why this is classified as C (50)

The patient-centered primary symptom endpoint favored wipes over active saline cleansing, but one small short trial with unmasked subjective reporting and incomplete randomized-set inclusion supports C with 50 points.

Counterpoint. C does not mean no effect; it recognizes short-term symptom benefit while noting no established superiority over hypochlorous acid and no confirmed durability.

Rejudgment record. Cross-check applied — Baseline-adjusted primary symptom results from an active-cleaning three-arm trial, tempered by missing randomized participants, small size, and short follow-up

Scoring profile behind this grade
EndpointPPatient-reported treatment goal - the symptom is the goal
ReplicationR1Single confirmatory trial
IndependenceI1Mixed funding sources
Effect sizeE+Meets the clinically important threshold

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Four-week symptom reduction versus saline-assisted mechanical cleansingCThe adjusted difference was significant at -13.35 points.
Symptom reduction versus hypochlorous-acid-assisted cleansingDThe confidence interval crossed zero.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Single-center assessor-masked three-arm randomized trial59PDF: “The authors received no specific funding for this work”; publisher page: three Chinese public grants; product provision not reportedPrimary: Week 4 eye-specific mean of eight VAS symptom items; secondary: OSDI and lid/ocular-surface signsAdjusted VAS 27.47 vs 33.16 vs 40.83; wipe-saline -13.35 (95% CI -21.51 to -5.20), wipe-hypochlorous acid -5.68 (-13.13 to 1.76)Only direct confirmatory evidence
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-08-08).

Shi R, Guo Y, Li A, et al. Comparative efficacy of eyelid cleansing wipes, hypochlorous acid, and saline for blepharitis-associated ocular surface disease: a randomized trial. Sci Rep. 2026. PMID: 42436201. DOI: 10.1038/s41598-026-62115-z.
checked
Savla K, Le JT, Pucker AD. Tea tree oil for Demodex blepharitis. Cochrane Database Syst Rev. 2020;6(6):CD013333. PMID: 32589270. PMCID: PMC7388771. DOI: 10.1002/14651858.CD013333.pub2.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-08 · Corrections: none

Cite this verdict

Eyelid cleansing wipes x reduced blepharitis symptoms Evidence Grade C card
[Chamgap] Eyelid cleansing wipes x reduced blepharitis symptoms — Evidence Grade C·50. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/eye/eyelid-cleansing-wipes-blepharitis-symptoms/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.